Akari Therapeutics Plc
New Filing
CIK: 0001541157·Other Health Care·UNITED KINGDOM·Filed: Jun 3, 2026
Total Offering
$5,500,000
Amount Sold
$1,833,333
Investors
6
First Sale
May 20, 2026
Offering Details
- Type
- Option to Acquire, Security to be Acquired, Other: American Depositary Shares (ADSs), each representing 80,000 Ordinary Shares
- Exemptions
- Rule 506(b)
- Entity Type
- Other
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Abizer Gaslightwala | |
| Kameel Farag | |
| Rob Bazemore | |
| Hoyoung Huh | |
| Jim Neal | |
| Ray Prudo | |
| Samir Patel | |
| Sandip Patel |
Company
SEC Filing
0001493152-26-027117
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free